Real-world data of olaparib maintenance therapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer: Final results of the C-PATROL study

被引：0
|
作者：
Marme, F. [1 ]
Hilpert, F. [2 ]
Welslau, M. [3 ]
Grabowski, J. P. [4 ,5 ]
Schneeweiss, A. [6 ,7 ]
Hartkopf, A. D. [8 ]
Becker, S. [9 ]
Runnebaum, I. [10 ]
Bauerschlag, D. [11 ]
Fasching, P. [12 ]
Brandi, C. [13 ]
Rehbein, J-K. [14 ]
Glowik, R. [15 ]
Sehouli, J. [16 ]
机构：
[1] UMM Univ Klinikum Mannheim, Dept Gynecol Oncol, Med Fak, Mannheim, Germany
[2] Krankenhaus Jerusalem, Mammazentrum, Hamburg, Germany
[3] Klinikum Aschaffenburg, Hamato Onkol Schwerpunktpraxis, Aschaffenburg, Germany
[4] Univ Klin Charite, Dept Gynecol, Berlin, Germany
[5] Campus Virchow Klinikum, Berlin, Germany
[6] Univ Hosp, Div Gynecol Oncol, Natl Ctr Tumor Dis NCT, Gynecol Oncol, Heidelberg, Germany
[7] German Canc Res Ctr, Heidelberg, Germany
[8] Univ Hosp Tuebingen, Ctr Womens Hlth Dept, Tubingen, Germany
[9] Goethe Univ Frankfurt Main, Dept Obstet & Gynecol, Campus Westend, Frankfurt, Germany
[10] Friedrich Schiller Univ Jena, Gynecol & Reprod Med, Jena, Germany
[11] Univ Hosp UKSH, Gynecol Oncol, Kiel, Germany
[12] Univ Klinikum Erlangen, Dept Gynecol & Obstet, Erlangen, Germany
[13] Agaples Med Versorgungszentrum Frankfurt gGmbH, Frauenheilkunde Gynakol, Frankfurt, Germany
[14] Stadt Krankenhaus Kiel GmbH, Frauenklin, Kiel, Germany
[15] AstraZeneca GmbH, Med Affairs, Hamburg, Germany
[16] Charite, Gynecol, Berlin, Germany
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1979
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
802P
引用
收藏
页码：S535 / S536
页数：2
相关论文
共 50 条
  • [21] Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer
    Vilming, Bente
    Fallas Dahl, Jorgen
    Bentzen, Anne Gry
    Ingebrigtsen, Vibeke Anett
    Berge Nilsen, Elisabeth
    Vistad, Ingvild
    Dorum, Anne
    Solheim, Olesya
    Bjorge, Line
    Zucknick, Manuela
    Aune, Guro
    Lindemann, Kristina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (12) : 1898 - 1905
  • [22] Comparisons of survival outcomes between bevacizumab and olaparib in BRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)
    Kim, Se Ik
    Lee, Jeong-Won
    Kim, Kidong
    Lee, Maria
    Yoo, Jigeun
    Choi, Min Chul
    Hwangbo, Suhyun
    Kwak, Young Hwa
    Lee, Jong-Min
    Shin, So-Jin
    Shim, Seung-Hyuk
    Kim, Min Kyu
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (06)
  • [23] NICE guidance on olaparib for maintenance treatment of patients with relapsed, platinum-sensitive, BRCA mutation-positive ovarian cancer
    Tucker, Helen
    Charles, Zoe
    Robertson, Janet
    Adam, Jane
    LANCET ONCOLOGY, 2016, 17 (03): : 277 - 278
  • [24] Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study
    Charlotte Bellier
    Laurence Gladieff
    Fanny Le Du
    Dominique Berton
    Charlotte Bonnard
    Delphine Suau
    Anne-Céline Richard
    Ophélie Brenner
    Amir Lahouegue
    Gilles Freyer
    Anne Floquet
    Sophie Frank
    Maria Kfoury
    Drugs - Real World Outcomes, 2023, 10 : 207 - 213
  • [25] Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer
    Moss, Haley A.
    Perhanidis, Jessica A.
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 50 - 56
  • [26] Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study
    Bellier, Charlotte
    Gladieff, Laurence
    Le Du, Fanny
    Berton, Dominique
    Bonnard, Charlotte
    Suau, Delphine
    Richard, Anne-Celine
    Brenner, Ophelie
    Lahouegue, Amir
    Freyer, Gilles
    Floquet, Anne
    Frank, Sophie
    Kfoury, Maria
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (02) : 207 - 213
  • [27] Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer
    Jonathan A Ledermann
    Philipp Harter
    Charlie Gourley
    Michael Friedlander
    Ignace Vergote
    Gordon Rustin
    Clare Scott
    Werner Meier
    Ronnie Shapira-Frommer
    Tamar Safra
    Daniela Matei
    Anitra Fielding
    Bryan Bennett
    David Parry
    Stuart Spencer
    Helen Mann
    Ursula Matulonis
    British Journal of Cancer, 2016, 115 : 1313 - 1320
  • [28] Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer
    Ledermann, Jonathan A.
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Fielding, Anitra
    Bennett, Bryan
    Parry, David
    Spencer, Stuart
    Mann, Helen
    Matulonis, Ursula
    BRITISH JOURNAL OF CANCER, 2016, 115 (11) : 1313 - 1320
  • [29] Maintenance therapy utilization in platinum-sensitive recurrent epithelial ovarian cancer: A 'real-world' analysis
    Moss, H. A.
    Havrilesky, L. J.
    Kauff, N. D.
    Secord, A. A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 204 - 204
  • [30] REPEATED USE OF MAINTENANCE THERAPY OLAPARIB IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSE OF OVARIAN CANCER
    Khokhlova, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A478 - A478
12345